Skip to main content
. Author manuscript; available in PMC: 2013 Feb 1.
Published in final edited form as: Phys Med Rehabil Clin N Am. 2011 Dec 13;23(1):187–xiii. doi: 10.1016/j.pmr.2011.11.010

Fig. 3.

Fig. 3

Weekly running distance for the MDX Run Leucine (MDX Run-L) group was greater at weeks 2, 3, and 4 (P<.05). Leucine treatment clearly improved whole animal endurance, suggesting potential changes in muscle metabolism and the cardiovascular system.